Purple Biotech annual total assets
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Purple Biotech Total Assets Growth & History (PPBT)
Purple Biotech's total assets was $17.6M for fiscal 2025.
View full Purple Biotech company overviewPurple Biotech annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $17.6M | −$19.5M | −52.56% |
| 2024 | 2024-12-31 | $37.0M | −$7.3M | −16.40% |
| 2023 | 2023-12-31 | $44.3M | −$10.3M | −18.89% |
| 2022 | 2022-12-31 | $54.6M | −$15.6M | −22.19% |
| 2021 | 2021-12-31 | $70.2M | −$13.6M | −16.23% |
| 2020 | 2020-12-31 | $83.8M | $69.1M | +469.39% |
| 2019 | 2019-12-31 | $14.7M | −$5,000 | −0.03% |
| 2018 | 2018-12-31 | $14.7M | $540,000 | +3.81% |
| 2017 | 2017-12-31 | $14.2M | −$731,000 | −4.90% |
| 2016 | 2016-12-31 | $14.9M | — | — |
Purple Biotech quarterly total assets
Q4.16
Q4.17
Q2.18
Q4.18
Q2.19
Q4.19
Q4.20
Q4.21
Q4.22
Q4.23
Q4.24
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $14.2M | −$20.2M | −58.79% |
| Q1 2026 | 2026-03-31 | $14.4M | — | — |
| Q4 2025 | 2025-12-31 | $17.6M | −$19.5M | −52.56% |
| Q3 2025 | 2025-09-30 | $39.1M | — | — |
| Q2 2025 | 2025-06-30 | $34.4M | — | — |
| Q4 2024 | 2024-12-31 | $37.0M | −$7.3M | −16.40% |
| Q4 2023 | 2023-12-31 | $44.3M | −$10.3M | −18.89% |
| Q4 2022 | 2022-12-31 | $54.6M | −$15.6M | −22.19% |
| Q4 2021 | 2021-12-31 | $70.2M | −$13.6M | −16.23% |
| Q4 2020 | 2020-12-31 | $83.8M | $69.1M | +469.39% |
| Q4 2019 | 2019-12-31 | $14.7M | −$5,000 | −0.03% |
| Q2 2019 | 2019-06-30 | $17.2M | −$1.2M | −6.45% |
| Q4 2018 | 2018-12-31 | $14.7M | $540,000 | +3.81% |
| Q2 2018 | 2018-06-30 | $18.4M | — | — |
| Q4 2017 | 2017-12-31 | $14.2M | −$731,000 | −4.90% |
| Q4 2016 | 2016-12-31 | $14.9M | — | — |
Purple Biotech total assets trends
Over the last five fiscal years, Purple Biotech's total assets decreased from $83.8M to $17.6M, a change of −$66.2M. The latest reported quarter, Q2 2026, shows $14.2M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Purple Biotech source filings ↗